- Disease: Mpox
- Study type: Observational Cohort Study, Prevention
- Study type descriptors: Prospective, Multicentre
- Objective: To compare the longevity of antibody responses from a subset of the All Ireland Infectious Disease Cohort following mpox infection and modified vaccinia Ankara–Bavarian Nordic (MVA–BN) vaccination
- Number of participants enrolled: 135
- Study enrolling from to
- Study includes follow-up for 2 years
Sites (9)
- St. Vincent’s University Hospital (Dublin, Ireland)
- St. Luke’s General Hospital (Kilkenny, Ireland)
- Beaumont Hospital (Dublin, Ireland)
- Wexford General Hospital (Wexford, Ireland)
- St. James’s Hospital (Dublin, Ireland)
- Our Lady of Lourdes Hospital (Drogheda, Ireland)
- Mater Misericordiae University Hospital (Dublin, Ireland)
- Cork University Hospital (Cork, Ireland)
- Children’s Health Ireland at Crumlin (Dublin, Ireland)
Study Data
- Adults (18-64 years)
- General population
- Hospital
- Monkeypox virus
- Mpox
- Blood sample
- Vaccination
- MVA-BN
External Links
Other information
Funders/Sponsors:
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to